Study Finds Strong Evidence of Smoking’s Role in Cancer, Chronic Lung Disease, Diabetes

Credit: Adobe Stock/mbruxelle

An analysis revealed strong causal relationships between smoking and several diseases, including obstructive chronic bronchitis, cancer of the bronchus, peripheral vascular disease, emphysema, pneumococcal pneumonia, chronic airway obstruction and type 2 diabetes. These findings underscore the wide-ranging health impacts of smoking and provide further evidence to promote smoking cessation efforts.

With a global estimate of eight million smoking-related deaths annually, smoking poses a significant health threat that contributes to a variety of chronic diseases.

“To fully grasp the complex impacts of smoking on these illnesses and elucidate possible underlying causes, a thorough examination of condition-related phenotypic clusters is crucial,” wrote a team of investigators from Central South University in China. “These groups effectively categorize diseases based on their distinct clinical characteristics, symptoms, and underlying biological pathways, thereby facilitating a nuanced exploration of smoking's impact on diverse disease processes and enabling the identification of vulnerable subpopulations as well as potential shared mechanisms between smoking and diseases.”

To determine any associations between smoking and disease patterns, investigators collected data from the UK Biobank, a large-scale biomedical repository encompassing comprehensive health-related database comprised of genetic information of people of European descent.

A phenome-wide association study (PheWAS) analysis was performed to determine the link between genetically predicted smoking status and 1549 phenotypes. These potential associations were examined through two-sample mendelian randomization (MR) analyses, using data from the UK Biobank and the Sequencing Consortium of Alcohol and Nicotine Use (GSCAN). The MR approach enabled investigators to further assess identified associations and determine any possible causal relationships.

PheWAS ultimately identified 34 phenotypes that showed significant associations with smoking. These types were further categorized into multiple systems, such as neuropsychiatric, dermatologic, respiratory, circulatory and hematologic.

A total of 15 diseases were significantly linked to at least three of the seven single nucleotide polymorphisms (SNPs) examined, including sickle cell anemia, type 2 diabetes, tobacco use disorders and chronic airway obstruction.

The most significant findings were the strong correlation between smoking and type 2 diabetes and sickle cell anemia (both 85.71% significant SNPs). The results further validate the understanding of the wide range of diseases that are related to smoking habits while offering useful perspectives into possible causal links between cigarettes and chronic conditions.

The MR analyses indicated causal associations between smoking and the risk of obstructive chronic bronchitis, cancer of the bronchus, emphysema, peripheral vascular disease, chronic airway obstruction, pneumococcal pneumonia and type 2 diabetes.

“These findings provide valuable insights into the causal relationship between smoking and various diseases, further emphasizing the detrimental health effects of smoking, particularly on outcomes such as type 2 diabetes and peripheral vascular disease,” investigators wrote.

Certain limitations much be acknowledged, including the inability to evaluate the causal relationship between smoking and certain conditions, such as tobacco use disorders and sickle cell anemia. Additionally, the relatively small sample size affected both generalizability and statistical power among patients with these particular conditions. Generalizability may have been further limited due to the narrow focus on data from European patients.

“By elucidating the genetic underpinnings of these associations, we provide valuable insights for developing targeted interventions and public health strategies,” investigators concluded. “This may help provide information for public health debate on smoking policy and prevention strategies to alleviate the burden of smoking-related disease.”